Erlotinib Active Not Recruiting Phase 1 Trials for Malignant Neoplasm of Colon / Renal Cancers / Colon Neoplasms / Lung Cancers / Breast Cancer / Neoplasms, Breast / Melanoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00600496A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)